FocusPerformancePartnership

Benoit FICHEUR has been promoted to Director, Mathilde DESANGES and Benjamin DIERICKX have been promoted to Associate Director, Marion ESTEVE GUILLEMAIN has been promoted to Associate

Publishing Date March 25, 2015

Last Updated September 30, 2026

Corporate News2 Mins Read
00:00 / 03:10

Publishing Date March 25, 2015

Last Updated September 30, 2026

2 Mins ReadCorporate News

ASTORG PARTNERS Is pleased to announce it has promoted Benoit Ficheur to Director, Mathilde Desanges and Benjamin Dierickx to Associate Director and Marion Esteve Guillemain to Associate.

Benoit FICHEUR joined Astorg in 2012 and is a member of the Investment team.

He has been involved in a number of transactions including Sebia and Gras Savoye.

Prior to this, Benoit founded Comptabis, a startup offering offshore accounting services, which he successfully sold in 2012. Previously, he spent 5 years with Cinven, where he was Principal.

He started his career as a Consultant with Bain & Cie in Paris and San Francisco, where he spent 3 years including a long-term assignment with the team dedicated to strategic due diligence for Private Equity funds.

Benoit graduated from HEC.


Mathilde DESANGES joined Astorg in 2013 and is a member of the Investment team.

She has been involved in several transactions including Sebia.

Prior to this, Mathilde was a Manager with McKinsey & Co in Paris for 6 years, where she primarily advised clients on strategy and performance improvement, mainly in the aerospace, energy and banking sectors.

Mathilde graduated from Ecole Polytechnique and HEC where she majored in Strategic Management.


Benjamin DIERICKX joined Astorg in 2010 and is a member of the Investment team.

He has been involved in a number of transactions including Megadyne and Metalor.

Prior to this, Benjamin spent 4 years with L.E.K. Consulting in Paris, where he specialised in strategic due diligences in the industry and professional services sectors.

Benjamin is an ESSEC graduate.


Marion ESTEVE GUILLEMAIN joined Astorg in 2012 and is a member of the Investment team.

She has been involved in a number of transactions including M7.

Prior to this, Marion spent 3 years with L.E.K. Consulting in Paris where she worked on several due diligence assignments in the industrial, energy and consumer goods sectors. During this period, she also spent 6 months at Fonds Stratégique d'Investissement (FSI) to assist investment teams in the strategic audit of potential acquisition targets.

Marion is an ESSEC graduate.

About ASTORG Partners

ASTORG Partners

Astorg is an independent private equity fund management company, specializing in European midmarket buyouts with total funds under management of over €2 billion. Astorg seeks to partner with successful and entrepreneurial management teams, to acquire businesses - very often family-owned - with attractive growth prospects, which Astorg supports through the provision of experienced governance and adequate capital. Astorg enjoys a distinct entrepreneurial culture, a long-term shareholder perspective, and a lean decision-making body enhancing its reactivity. Although a multi-sector investor, Astorg has developed solid industry expertise in healthcare, B2B professional services, and niche industrial companies selling differentiated, often technology-driven, products. Visit www.astorg-partners.com for more information.

Further Information

Delivering consistent performance
across every investment

Related Hub content

Astorg VIII Reaches €4 Billion At Interim Closing
ViewMore
Corporate News
news
Astorg VIII Reaches €4 Billion At Interim Closing
Euromoney Institutional Investor PLC  (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
ViewMore
Corporate News
news
Euromoney Institutional Investor PLC (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
Astorg 2020 Year in Review
ViewMore
Corporate News
news
Astorg 2020 Year in Review
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ViewMore
Corporate News
news
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
SGG Group acquires Augentius
ViewMore
Corporate News
news
SGG Group acquires Augentius
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
ViewMore
Corporate News
news
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
SGG Group acquires Cim Global Business in Mauritius
ViewMore
Corporate News
news
SGG Group acquires Cim Global Business in Mauritius
Guillaume de Malliard to join ASTORG PARTNERS as Partner
ViewMore
Corporate News
news
Guillaume de Malliard to join ASTORG PARTNERS as Partner
Cobepa sells SGG to Astorg Partners and management
ViewMore
Corporate News
news
Cobepa sells SGG to Astorg Partners and management
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
ViewMore
Corporate News
news
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
Judith CHARPENTIER has been promoted to Director;Thomas CARBONEL has been promoted to Associate Director and Charles-Hubert LE BARON has been promoted to Associate
ViewMore
Corporate News
news
Judith CHARPENTIER has been promoted to Director;Thomas CARBONEL has been promoted to Associate Director and Charles-Hubert LE BARON has been promoted to Associate
Marion Guillemain joins Astorg Partners as an Analyst
ViewMore
Corporate News
news
Marion Guillemain joins Astorg Partners as an Analyst
Astorg VIII Reaches €4 Billion At Interim Closing
ViewMore
Corporate News
news
Astorg VIII Reaches €4 Billion At Interim Closing
Euromoney Institutional Investor PLC  (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
ViewMore
Corporate News
news
Euromoney Institutional Investor PLC (the “Group” or “Euromoney”) Euromoney announces the completion of the acquisition by Astorg and Epiris
Astorg 2020 Year in Review
ViewMore
Corporate News
news
Astorg 2020 Year in Review
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ViewMore
Corporate News
news
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
SGG Group acquires Augentius
ViewMore
Corporate News
news
SGG Group acquires Augentius
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
ViewMore
Corporate News
news
Astorg appoints François de Mitry as Managing Partner and bolsters its teams in Germany and in London
SGG Group acquires Cim Global Business in Mauritius
ViewMore
Corporate News
news
SGG Group acquires Cim Global Business in Mauritius
Guillaume de Malliard to join ASTORG PARTNERS as Partner
ViewMore
Corporate News
news
Guillaume de Malliard to join ASTORG PARTNERS as Partner
Cobepa sells SGG to Astorg Partners and management
ViewMore
Corporate News
news
Cobepa sells SGG to Astorg Partners and management
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
ViewMore
Corporate News
news
Astorg - Team Promotions Lorenzo ZAMBONI and Stéphane EPIN have been co-opted as Partners
Judith CHARPENTIER has been promoted to Director;Thomas CARBONEL has been promoted to Associate Director and Charles-Hubert LE BARON has been promoted to Associate
ViewMore
Corporate News
news
Judith CHARPENTIER has been promoted to Director;Thomas CARBONEL has been promoted to Associate Director and Charles-Hubert LE BARON has been promoted to Associate
Marion Guillemain joins Astorg Partners as an Analyst
ViewMore
Corporate News
news
Marion Guillemain joins Astorg Partners as an Analyst